SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL… Application WO-2022266203-A1 World Intellectual Property Organisation (WIPO) 22 Dec 2022
ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS… Application WO-2021260657-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2021
A METHOD OF ENGINEERING NATURAL KILLER CELLS TO TARGET CD70-POSITIVE TUMORS Application WO-2021142127-A1 World Intellectual Property Organisation (WIPO) 15 Jul 2021